Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Aug;69(8):5147–5151. doi: 10.1128/jvi.69.8.5147-5151.1995

Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor.

R B Roden 1, N L Hubbert 1, R Kirnbauer 1, F Breitburd 1, D R Lowy 1, J T Schiller 1
PMCID: PMC189336  PMID: 7541848

Abstract

Virus-like particles (VLPs) composed of L1 derived from bovine papillomavirus type 1 (BPV-1), several human papillomavirus types, or cottontail rabbit papillomavirus (CRPV) agglutinated mouse but not human or rat erythrocytes. Treatment of mouse erythrocytes with trypsin prevented hemagglutination (HA) by BPV-1. Sera from rabbits immunized with native CRPV VLPs, which protect against experimental CRPV infection, exhibited high titers of antibodies that inhibited CRPV VLP HA activity, while sera from rabbits immunized with denatured CRPV VLPs or native BPV VLPs, which do not protect against CRPV infection, were not inhibitory. Testing for HA inhibition is a rapid and simple method for examining the serological relatedness of papillomaviruses and measuring protective antibody titers after VLP vaccination.

Full Text

The Full Text of this article is available as a PDF (415.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker T. S., Newcomb W. W., Olson N. H., Cowsert L. M., Olson C., Brown J. C. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J. 1991 Dec;60(6):1445–1456. doi: 10.1016/S0006-3495(91)82181-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 1995 Jun;69(6):3959–3963. doi: 10.1128/jvi.69.6.3959-3963.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown K. E., Anderson S. M., Young N. S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993 Oct 1;262(5130):114–117. doi: 10.1126/science.8211117. [DOI] [PubMed] [Google Scholar]
  4. Butel J. S. Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst. 1972 Feb;48(2):285–299. [PubMed] [Google Scholar]
  5. Christensen N. D., Kreider J. W. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J Virol. 1990 Jul;64(7):3151–3156. doi: 10.1128/jvi.64.7.3151-3156.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crawford L. Prospects for cervical cancer vaccines. Cancer Surv. 1993;16:215–229. [PubMed] [Google Scholar]
  7. Dvoretzky I., Shober R., Chattopadhyay S. K., Lowy D. R. A quantitative in vitro focus assay for bovine papilloma virus. Virology. 1980 Jun;103(2):369–375. doi: 10.1016/0042-6822(80)90195-6. [DOI] [PubMed] [Google Scholar]
  8. Favre M., Breitburd F., Croissant O., Orth G. Hemagglutinating activity of bovine papilloma virus. Virology. 1974 Aug;60(2):572–578. doi: 10.1016/0042-6822(74)90351-1. [DOI] [PubMed] [Google Scholar]
  9. Fried H., Cahan L. D., Paulson J. C. Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. Virology. 1981 Feb;109(1):188–192. doi: 10.1016/0042-6822(81)90485-2. [DOI] [PubMed] [Google Scholar]
  10. Ghim S., Christensen N. D., Kreider J. W., Jenson A. B. Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer. 1991 Sep 9;49(2):285–289. doi: 10.1002/ijc.2910490224. [DOI] [PubMed] [Google Scholar]
  11. Hagensee M. E., Olson N. H., Baker T. S., Galloway D. A. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol. 1994 Jul;68(7):4503–4505. doi: 10.1128/jvi.68.7.4503-4505.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haywood A. M. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol. 1994 Jan;68(1):1–5. doi: 10.1128/jvi.68.1.1-5.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jin Y. M., Pardoe I. U., Burness A. T., Michalak T. I. Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells. J Virol. 1994 Nov;68(11):7308–7319. doi: 10.1128/jvi.68.11.7308-7319.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kirnbauer R., Booy F., Cheng N., Lowy D. R., Schiller J. T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180–12184. doi: 10.1073/pnas.89.24.12180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kirnbauer R., Hubbert N. L., Wheeler C. M., Becker T. M., Lowy D. R., Schiller J. T. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst. 1994 Apr 6;86(7):494–499. doi: 10.1093/jnci/86.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kirnbauer R., Taub J., Greenstone H., Roden R., Dürst M., Gissmann L., Lowy D. R., Schiller J. T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol. 1993 Dec;67(12):6929–6936. doi: 10.1128/jvi.67.12.6929-6936.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Larsen P. M., Storgaard L., Fey S. J. Proteins present in bovine papillomavirus particles. J Virol. 1987 Nov;61(11):3596–3601. doi: 10.1128/jvi.61.11.3596-3601.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Müller M., Gissmann L., Cristiano R. J., Sun X. Y., Frazer I. H., Jenson A. B., Alonso A., Zentgraf H., Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol. 1995 Feb;69(2):948–954. doi: 10.1128/jvi.69.2.948-954.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Roden R. B., Kirnbauer R., Jenson A. B., Lowy D. R., Schiller J. T. Interaction of papillomaviruses with the cell surface. J Virol. 1994 Nov;68(11):7260–7266. doi: 10.1128/jvi.68.11.7260-7266.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Roden R. B., Weissinger E. M., Henderson D. W., Booy F., Kirnbauer R., Mushinski J. F., Lowy D. R., Schiller J. T. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol. 1994 Nov;68(11):7570–7574. doi: 10.1128/jvi.68.11.7570-7574.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. WHITE D. O., HUEBNER R. J., ROWE W. P., TRAUB R. Studies on the virus of rabbit papilloma. 1. Methods of assay. Aust J Exp Biol Med Sci. 1963 Feb;41:41–50. doi: 10.1038/icb.1963.3. [DOI] [PubMed] [Google Scholar]
  22. Weis W., Brown J. H., Cusack S., Paulson J. C., Skehel J. J., Wiley D. C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 1988 Jun 2;333(6172):426–431. doi: 10.1038/333426a0. [DOI] [PubMed] [Google Scholar]
  23. White J. M., Littman D. R. Viral receptors of the immunoglobulin superfamily. Cell. 1989 Mar 10;56(5):725–728. doi: 10.1016/0092-8674(89)90674-0. [DOI] [PubMed] [Google Scholar]
  24. Zhou J., Stenzel D. J., Sun X. Y., Frazer I. H. Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol. 1993 Apr;74(Pt 4):763–768. doi: 10.1099/0022-1317-74-4-763. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES